Strategies to Mitigate the Bioactivation of Aryl Amines-Reference-Cited by-同舟云学术

Strategies to Mitigate the Bioactivation of Aryl Amines

Published:2020-06-08 Issue:7 Volume:33 Page:1950-1959
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Zhang Chenghong¹,Crawford James J.¹^ORCID,Landry Matthew L.¹,Chen Huifen¹^ORCID,Kenny Jane R.¹,Khojasteh S. Cyrus¹,Lee Wendy¹,Ma Shuguang¹,Young Wendy B.¹^ORCID

Affiliation:

1. Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States

Funder

Genentech

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrestox.0c00138

Reference36 articles.

1. Trends in clinical success rates

2. Estimation of clinical trial success rates and related parameters

3. Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results

4. Idiosyncratic drug-induced liver injury: an overview

5. Drug-induced liver injury: a clinical update

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deriving insights for molecular design with MMP analysis;Trends in Chemistry;2024-07

2. Electrochemical Nitro Reduction to Amines Using Pinacolborane as Reducing Agent;Synlett;2024-05-08

3. Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies;Journal of Medicinal Chemistry;2024-02-01

4. Idiosyncratic drug reactions and toxicities;Public Health and Toxicology Issues Drug Research, Volume 2;2024

5. DRUG-INDUCED LIVER INJURY: MECHANISMS, METHODS FOR PRE-CLINICAL ASSESSMENT, AND A MEDICINAL CHEMIST’S PERSPECTIVE;Medicinal Chemistry Reviews;2023-11-16